Advisor OS LLC Cuts Stock Position in MetLife, Inc. (NYSE:MET)

Advisor OS LLC trimmed its holdings in shares of MetLife, Inc. (NYSE:METFree Report) by 13.6% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 4,149 shares of the financial services provider’s stock after selling 654 shares during the period. Advisor OS LLC’s holdings in MetLife were worth $291,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in MET. Forum Financial Management LP boosted its position in MetLife by 1.0% during the 2nd quarter. Forum Financial Management LP now owns 13,729 shares of the financial services provider’s stock worth $964,000 after acquiring an additional 141 shares during the period. Drive Wealth Management LLC lifted its holdings in MetLife by 3.5% in the second quarter. Drive Wealth Management LLC now owns 4,217 shares of the financial services provider’s stock worth $296,000 after purchasing an additional 141 shares during the period. Hills Bank & Trust Co grew its position in MetLife by 8.3% in the 2nd quarter. Hills Bank & Trust Co now owns 1,855 shares of the financial services provider’s stock valued at $130,000 after buying an additional 142 shares in the last quarter. CNB Bank increased its stake in MetLife by 9.3% during the 1st quarter. CNB Bank now owns 1,735 shares of the financial services provider’s stock valued at $129,000 after buying an additional 147 shares during the period. Finally, Marcum Wealth LLC raised its position in shares of MetLife by 4.7% during the 1st quarter. Marcum Wealth LLC now owns 3,436 shares of the financial services provider’s stock worth $255,000 after buying an additional 153 shares in the last quarter. 89.81% of the stock is currently owned by institutional investors and hedge funds.

MetLife Stock Performance

MetLife stock opened at $74.08 on Monday. MetLife, Inc. has a fifty-two week low of $57.91 and a fifty-two week high of $79.34. The firm’s 50 day simple moving average is $73.32 and its 200-day simple moving average is $72.10. The company has a debt-to-equity ratio of 0.56, a current ratio of 0.16 and a quick ratio of 0.16. The company has a market cap of $52.68 billion, a P/E ratio of 25.46, a price-to-earnings-growth ratio of 0.62 and a beta of 1.04.

MetLife (NYSE:METGet Free Report) last announced its earnings results on Wednesday, July 31st. The financial services provider reported $2.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.13 by $0.15. The company had revenue of $17.82 billion for the quarter, compared to the consensus estimate of $18.57 billion. MetLife had a net margin of 4.23% and a return on equity of 21.41%. The company’s revenue was up 7.2% on a year-over-year basis. During the same period in the previous year, the business earned $1.94 EPS. As a group, equities research analysts predict that MetLife, Inc. will post 8.68 EPS for the current year.

MetLife Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 10th. Shareholders of record on Tuesday, August 6th will be paid a dividend of $0.545 per share. The ex-dividend date of this dividend is Tuesday, August 6th. This represents a $2.18 annualized dividend and a yield of 2.94%. MetLife’s dividend payout ratio (DPR) is presently 74.91%.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the stock. Wells Fargo & Company increased their price objective on shares of MetLife from $85.00 to $86.00 and gave the company an “overweight” rating in a report on Monday, August 12th. Keefe, Bruyette & Woods decreased their price target on MetLife from $86.00 to $85.00 and set an “outperform” rating for the company in a research note on Monday, July 8th. Bank of America dropped their price objective on MetLife from $99.00 to $96.00 and set a “buy” rating on the stock in a research note on Thursday, August 1st. Barclays initiated coverage on MetLife in a research note on Wednesday, September 4th. They set an “overweight” rating and a $91.00 target price for the company. Finally, Citigroup boosted their price target on shares of MetLife from $83.00 to $89.00 and gave the stock a “buy” rating in a research report on Tuesday, July 23rd. One investment analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat, MetLife presently has a consensus rating of “Moderate Buy” and a consensus price target of $84.54.

Get Our Latest Stock Report on MET

About MetLife

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Read More

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.